Skip to content
10-Q

Quarterly Report

GENOCEA BIOSCIENCES, INC.

0001457612-21-000102

← back to feed
Filed
Oct 28, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Oct 25, 2021 57.45M sh
Shares Diluted Q3 2021 · Sep 30, 2021 69.81M sh
Shares Diluted Q3 2021 · Sep 30, 2021 70.62M sh
Shares Diluted Q3 2021 · Sep 30, 2020 61.13M sh
Shares Diluted Q3 2021 · Sep 30, 2020 39.55M sh
Capex Q3 2021 · Sep 30, 2021 $2.35M
Capex Q3 2021 · Sep 30, 2020 $1.21M
Operating Cash Flow Q3 2021 · Sep 30, 2021 −$34.27M
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$32.01M
Long Term Debt Q3 2021 · Sep 30, 2021 $5.33M
Long Term Debt Q3 2021 · Dec 31, 2020 $0
Short Term Debt Q3 2021 · Sep 30, 2021 $4.58M
Short Term Debt Q3 2021 · Dec 31, 2020 $13.86M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $48.91M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $79.77M
Stockholders Equity Q3 2021 · Sep 30, 2021 $37.83M
Stockholders Equity Q3 2021 · Jun 30, 2021 $4.06M
Stockholders Equity Q3 2021 · Mar 31, 2021 $1.76M
Stockholders Equity Q3 2021 · Dec 31, 2020 $8.98M
Stockholders Equity Q3 2021 · Sep 30, 2020 $20.21M
Stockholders Equity Q3 2021 · Jun 30, 2020 $8.04M
Stockholders Equity Q3 2021 · Mar 31, 2020 $13.01M
Stockholders Equity Q3 2021 · Dec 31, 2019 $25.04M
Current Liabilities Q3 2021 · Sep 30, 2021 $14.7M
Current Liabilities Q3 2021 · Dec 31, 2020 $25M
Total Liabilities Q3 2021 · Sep 30, 2021 $27.09M
Total Liabilities Q3 2021 · Dec 31, 2020 $89.51M
Current Assets Q3 2021 · Sep 30, 2021 $50.61M
Current Assets Q3 2021 · Dec 31, 2020 $82.23M
Total Assets Q3 2021 · Sep 30, 2021 $64.92M
Total Assets Q3 2021 · Dec 31, 2020 $98.49M
Eps Diluted Q3 2021 · Sep 30, 2021 −$0.05
Eps Diluted Q3 2021 · Sep 30, 2021 −$0.54
Eps Diluted Q3 2021 · Sep 30, 2020 −$0.26
Eps Diluted Q3 2021 · Sep 30, 2020 −$1.01
Eps Basic Q3 2021 · Sep 30, 2021 −$0.05
Eps Basic Q3 2021 · Sep 30, 2021 −$0.29
Eps Basic Q3 2021 · Sep 30, 2020 −$0.08
Eps Basic Q3 2021 · Sep 30, 2020 −$0.76
Sga Expense Q3 2021 · Sep 30, 2021 $3.88M
Sga Expense Q3 2021 · Sep 30, 2021 $11.59M
Sga Expense Q3 2021 · Sep 30, 2020 $3.64M
Sga Expense Q3 2021 · Sep 30, 2020 $10.51M
Rd Expense Q3 2021 · Sep 30, 2021 $9.47M
Rd Expense Q3 2021 · Sep 30, 2021 $28.74M
Rd Expense Q3 2021 · Sep 30, 2020 $7.55M
Rd Expense Q3 2021 · Sep 30, 2020 $26.12M
Net Income Q3 2021 · Sep 30, 2021 −$3.62M
Net Income Q3 2021 · Sep 30, 2021 −$19.92M
Net Income Q3 2021 · Jun 30, 2021 −$4.31M
Net Income Q3 2021 · Mar 31, 2021 −$11.98M
Net Income Q3 2021 · Sep 30, 2020 −$4.56M
Net Income Q3 2021 · Sep 30, 2020 −$28.73M
Net Income Q3 2021 · Jun 30, 2020 −$11.32M
Net Income Q3 2021 · Mar 31, 2020 −$12.85M
Operating Income Q3 2021 · Sep 30, 2021 −$11.72M
Operating Income Q3 2021 · Sep 30, 2021 −$38.68M
Operating Income Q3 2021 · Sep 30, 2020 −$10.74M
Operating Income Q3 2021 · Sep 30, 2020 −$35.28M